BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12070603)

  • 1. Leukotriene A(4)-hydrolase expression and leukotriene B(4) levels in chronic inflammation of bacterial origin: immunohistochemistry and reverse-phase high-performance liquid chromatography analysis of oral mucosal epithelium.
    Eberhard J; Jepsen S; Tiemann M; Krause R; Açil Y; Albers HK
    Virchows Arch; 2002 Jun; 440(6):627-34. PubMed ID: 12070603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of LTA(4) hydrolase expression in human monocytes by gamma-interferon and interleukins 4 and 13: potential relevance to leukotriene regulation in glomerular disease.
    Montero A; Nassar GM; Uda S; Munger KA; Badr KF
    Exp Nephrol; 2000; 8(4-5):258-65. PubMed ID: 10940725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness.
    Rao NL; Riley JP; Banie H; Xue X; Sun B; Crawford S; Lundeen KA; Yu F; Karlsson L; Fourie AM; Dunford PJ
    Am J Respir Crit Care Med; 2010 May; 181(9):899-907. PubMed ID: 20110560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis.
    Chen M; Lam BK; Luster AD; Zarini S; Murphy RC; Bair AM; Soberman RJ; Lee DM
    J Immunol; 2010 Nov; 185(9):5503-11. PubMed ID: 20876351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New induction of leukotriene A(4) hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes.
    Zaitsu M; Hamasaki Y; Matsuo M; Kukita A; Tsuji K; Miyazaki M; Hayasaki R; Muro E; Yamamoto S; Kobayashi I; Ichimaru T; Kohashi O; Miyazaki S
    Blood; 2000 Jul; 96(2):601-9. PubMed ID: 10887124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase of LTB4 level and expression of LTA4-hydrolase mRNA in lung tissue and cerebral cortex in asthmatic rats].
    Deng YM; Xie QM; Chen JQ; Deng JF; Bian RL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):296-9, 322. PubMed ID: 12970929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
    Penning TD; Chandrakumar NS; Chen BB; Chen HY; Desai BN; Djuric SW; Docter SH; Gasiecki AF; Haack RA; Miyashiro JM; Russell MA; Yu SS; Corley DG; Durley RC; Kilpatrick BF; Parnas BL; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Krivi GG; Villani-Price D; Pyla EY; Smith WG
    J Med Chem; 2000 Feb; 43(4):721-35. PubMed ID: 10691697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
    Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased leukotriene A(4) hydrolase expression in the heart of angiotensin II-induced hypertensive rat.
    Ishizaka N; Nakao A; Ohishi N; Suzuki M; Aizawa T; Taguchi J; Nagai R; Shimizu T; Ohno M
    FEBS Lett; 1999 Dec; 463(1-2):155-9. PubMed ID: 10601658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysema.
    Shim YM; Paige M; Hanna H; Kim SH; Burdick MD; Strieter RM
    Am J Physiol Lung Cell Mol Physiol; 2010 Dec; 299(6):L749-59. PubMed ID: 20817777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
    Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.
    Snelgrove RJ; Jackson PL; Hardison MT; Noerager BD; Kinloch A; Gaggar A; Shastry S; Rowe SM; Shim YM; Hussell T; Blalock JE
    Science; 2010 Oct; 330(6000):90-4. PubMed ID: 20813919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.
    Liang AM; Claret E; Ouled-Diaf J; Jean A; Vogel D; Light DR; Jones SW; Guilford WJ; Parkinson JF; Snider RM
    J Biomol Screen; 2007 Jun; 12(4):536-45. PubMed ID: 17384330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.
    Oi N; Jeong CH; Nadas J; Cho YY; Pugliese A; Bode AM; Dong Z
    Cancer Res; 2010 Dec; 70(23):9755-64. PubMed ID: 20952510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-inflammatory mediators change leukotriene B4 and leukotriene C4 synthesis and secretion in an inflamed porcine endometrium.
    Czarzasta J; Andronowska A; Jana B
    Domest Anim Endocrinol; 2014 Oct; 49():49-59. PubMed ID: 25010026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of leukotriene A4 hydrolase activity in endothelial cells by phosphorylation.
    Rybina IV; Liu H; Gor Y; Feinmark SJ
    J Biol Chem; 1997 Dec; 272(50):31865-71. PubMed ID: 9395533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of leukotriene B(4) in human sputum as a biomarker using UPLC-MS/MS.
    Jian W; Edom RW; Xue X; Huang MQ; Fourie A; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():59-65. PubMed ID: 23831697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments.
    Hicks A; Monkarsh SP; Hoffman AF; Goodnow R
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1909-20. PubMed ID: 18042000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.
    Calışkan B; Banoglu E
    Expert Opin Drug Discov; 2013 Jan; 8(1):49-63. PubMed ID: 23095029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.